Optogenetic control of cancer cell survival in ChR2-transfected HeLa cells

Claudio Córdova1, Carlo Lozano2, Belén Rodríguez1

  • 1Laboratorio de Estructura y Función Celular, Escuela de Medicina, Facultad de Medicina, Universidad de Valparaíso, Valparaíso, Chile.

Insights

Optogenetics allows control over HeLa cell survival using blue light stimulation after transfection with channelrhodopsin-2 (ChR2). Cell death is linked to high calcium levels and specific light stimulation intervals.

Area of Science:

  • Molecular Biology
  • Optogenetics
  • Cell Biology

Background:

  • Optogenetics utilizes photosensitive proteins to study cellular functions.
  • Channelrhodopsin-2 (ChR2) is a photosensitive protein used in optogenetic research.
  • Controlling cell survival via optogenetics is crucial for biomedical applications.

Purpose of the Study:

  • To investigate the impact of blue light on the survival of HeLa cells engineered with ChR2.
  • To establish a method for optogenetic control of cell survival in a cell culture environment.

Main Methods:

  • HeLa cells were transfected with the ChR2 gene.
  • Transfection and ChR2 function were confirmed using RT-PCR, fluorescence imaging (GFP), and flow cytometry (intracellular calcium).
  • A custom platform delivered blue light (467 nm) stimulation for up to 24 hours; cell survival was assessed via flow cytometry (propidium iodide, rhodamine).

Main Results:

  • A statistically significant inverse relationship was observed between light stimulation frequency/duration and HeLa cell survival (p < 0.05).
  • Cell death correlated with elevated intracellular calcium levels and stimulation intervals shorter than the ChR2 isomerization cycle.
  • Successful transfection and optogenetic control of cell survival were demonstrated.

Conclusions:

  • HeLa cells can be successfully transfected with ChR2 for controlled survival under blue light.
  • The findings suggest potential applications in developing future optogenetic systems for biological and biomedical research.
  • Understanding the ChR2 cis-trans-isomerization cycle is key to managing cell survival during optogenetic stimulation.